GlassScriptPhysician profile
William J Jordan
NPI 1437349420
$5,337.72
in general payments reported to CMS, 2019-2025
8 companies · $1,308 in 2025
The $1,308 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.73 · 2020: $2,398 · 2021: $416 · 2024: $1,121 · 2025: $1,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,891 · Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,890.89 |
| Food and Beverage | $538.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $2,306.20 | 2020 | |
| Arthrex, INC. | $1,432.18 | 2024-2025 | |
| Medinc of Texas | $996.97 | 2024-2025 | |
| Stryker Corporation | $485.07 | 2019-2021 | |
| Abbott Laboratories | $66.76 | 2021 | |
| Vericel Corporation | $20.48 | 2020 | |
| Bioventus LLC | $15.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.88 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.